| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $286K | -35.1% |
| Cost of Revenue | $57K | -71.4% |
| Gross Profit | $229K | -5.4% |
| R&D Expense | $5.8M | +3.9% |
| SG&A Expense | $21.4M | -23.2% |
| Operating Income | -$27.3M | +18.4% |
| Pre-tax Income | -$27.3M | +17.0% |
| Income Tax | $0 | — |
| Net Income | -$27.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $400K | -96.6% |
| Accounts Receivable | $9K | — |
| Inventory | $336K | -82.1% |
| Current Assets | $1.1M | -91.9% |
| Total Assets | $4.1M | -73.5% |
| Current Liabilities | $3.3M | +26.6% |
| Total Liabilities | $3.7M | +25.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.7M | +17.8% |
| Capital Expenditures | $168K | -69.0% |
| Investing Cash Flow | -$168K | +69.0% |
| Financing Cash Flow | $10.6M | +2.3% |
| Free Cash Flow | -$21.9M | +18.8% |
| +15.2% |
| Stockholders' Equity |
| $313K |
| -97.4% |